Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PET/CT of Nicotine Distribution in E-cigarette Users
NCT03491059Phase 4Active, not recruiting
- Sponsor
- University of Cincinnati
- Start
- Feb 2018
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of nicotine C-11 (2 arms), sponsored by University of Cincinnati. Primary endpoints: Nicotine biodistribution at 10 months, Nicotine uptake at 10 months and 1 more. Started Feb 2018; status: active, not recruiting.
02
Drugs
nicotine C-11
Beyond the preview
Go deeper on NCT03491059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03491059.